Visit Our Blog
  • FDNA Telehealth
    • Genetic Counseling For Rare Diseases
    • Rare Disease Guide
    • Rare Genetic Syndromes
    • Rare Genetic Symptoms
  • Products
    • Face2Gene Labs
    • Face2Gene Clinic
    • Genetic Analysis via Telehealth
  • About FDNA
  • News & Press
    • In The News
    • Press Releases
  • Contact
  • FDNA Insights

FDNA Insights

Categories
  • All
  • 2018
  • ACMG
  • Case Study
  • Events/Conferences
  • Face2Gene
  • Genomics
  • Pharma
  • Pharma
  • Phenotyping
  • Rare Diseases
  • Scientific Abstracts
  • Talks
  • Technology
  • Uncategorized
  • Videos
  • Webinar

ACMG

ACMG
 

ACMG Meeting 2020

  The FDNA team is gearing up for ACMG 2020 and we’re excited to share with you new developments and Read more

ACMG
 

Precision Medicine and the Integration of Next-Generation Phenotyping

By Dr. Karen Gripp, Chief Medical Officer at FDNA Next-generation phenotyping (NGP) is characterized by the use of computer learning Read more

ACMG
 

Dr. Christine Stanley: Face2Gene LABS at WuXi NextCODE: Phenotyping for Improved Variant Prioritization

Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this link> Read more

ACMG
 

Dr. John Carey: Delineating Genetic Syndromes and Next-Generation Phenotyping

Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this Read more

ACMG
 

Dr. Karen Gripp: Face2Gene RESEARCH for Deep Phenotyping of Novel Syndromes

Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this Read more

  • Contact Us
  • FDNA Telehealth
  • Privacy Policy
  • Terms of Use

Signup for News


* These fields are required.

© 2011-2021 FDNA INC. www.FDNA.com. All rights reserved.

Face2Gene is a search and reference tool provided for informational purposes and not intended to replace the clinician’s judgment or experience, nor should it be used to diagnose or treat medical conditions.